|Dr. Siddhartha Chandrakant Kadia B.E., M.S., Ph.D.||CEO & Director||17.97k||N/A||1970|
|Dr. Keith J. Breinlinger Ph.D.||Chief Technology Officer||467.41k||4.34M||1974|
|Dr. Eric D. Hobbs Ph.D.||Pres of the Antibody Therapeutics Bus.||667.73k||22.99M||1978|
|Mr. Mehul Joshi||Chief Financial Officer||N/A||N/A||N/A|
|Mr. James Paul McClaskey||Sr. VP & Chief Accounting Officer||N/A||N/A||1978|
|Dr. Rolando Brawer Ph.D.||Exec. VP of Strategy & Corp. Devel.||N/A||N/A||N/A|
|Ms. Sheri Kelleher||VP of People Success||N/A||N/A||N/A|
|Mr. Lucas S. Vitale||Chief HR Officer||N/A||N/A||1976|
Berkeley Lights, Inc., a digital cell biology company, focuses on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products. The company offers an integrated platform, which comprise of proprietary consumables, including OptoSelect chips and reagent kits, automation systems, and application and workflow software. It serves in North America, the Asia Pacific, and Europe. Berkeley Lights, Inc. was incorporated in 2011 and is headquartered in Emeryville, California.
Berkeley Lights, Inc.’s ISS Governance QualityScore as of July 31, 2022 is 9. The pillar scores are Audit: 6; Board: 9; Shareholder Rights: 8; Compensation: 9.